BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16077730)

  • 1. Mutation spectrum leading to an attenuated phenotype in dystrophinopathies.
    Tuffery-Giraud S; Saquet C; Thorel D; Disset A; Rivier F; Malcolm S; Claustres M
    Eur J Hum Genet; 2005 Dec; 13(12):1254-60. PubMed ID: 16077730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
    Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
    Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects.
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Hum Mutat; 1999; 14(5):359-68. PubMed ID: 10533061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
    Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
    Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proximal dystrophin gene deletions and protein alterations in becker muscular dystrophy.
    Novaković I; Bojić D; Todorović S; Apostolski S; Luković L; Stefanović D; Milasin J
    Ann N Y Acad Sci; 2005 Jun; 1048():406-10. PubMed ID: 16154963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
    Kerr TP; Sewry CA; Robb SA; Roberts RG
    Hum Genet; 2001 Oct; 109(4):402-7. PubMed ID: 11702221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
    Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
    Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.
    Hamed S; Sutherland-Smith A; Gorospe J; Kendrick-Jones J; Hoffman E
    Clin Genet; 2005 Jul; 68(1):69-79. PubMed ID: 15952989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations in Czech DMD/BMD patients and their phenotypic outcome.
    Sedlácková J; Vondrácek P; Hermanová M; Zámecník J; Hrubá Z; Haberlová J; Kraus J; Maríková T; Hedvicáková P; Vohánka S; Fajkusová L
    Neuromuscul Disord; 2009 Nov; 19(11):749-53. PubMed ID: 19783145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of point mutations in Turkish DMD/BMD families using multiplex-single stranded conformation analysis (SSCA).
    Eraslan S; Kayserili H; Apak MY; Kirdar B
    Eur J Hum Genet; 1999; 7(7):765-70. PubMed ID: 10573008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients.
    Helderman-van den Enden AT; Straathof CS; Aartsma-Rus A; den Dunnen JT; Verbist BM; Bakker E; Verschuuren JJ; Ginjaar HB
    Neuromuscul Disord; 2010 Apr; 20(4):251-4. PubMed ID: 20153965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families.
    Elhawary NA; Shawky RM; Hashem N
    Mol Cells; 2004 Oct; 18(2):141-9. PubMed ID: 15528988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
    Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
    Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.
    Okubo M; Noguchi S; Hayashi S; Nakamura H; Komaki H; Matsuo M; Nishino I
    Hum Genet; 2020 Feb; 139(2):247-255. PubMed ID: 31919629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.
    Wagner KR; Hamed S; Hadley DW; Gropman AL; Burstein AH; Escolar DM; Hoffman EP; Fischbeck KH
    Ann Neurol; 2001 Jun; 49(6):706-11. PubMed ID: 11409421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.
    Shiga N; Takeshima Y; Sakamoto H; Inoue K; Yokota Y; Yokoyama M; Matsuo M
    J Clin Invest; 1997 Nov; 100(9):2204-10. PubMed ID: 9410897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family.
    Ginjaar IB; Kneppers AL; v d Meulen JD; Anderson LV; Bremmer-Bout M; van Deutekom JC; Weegenaar J; den Dunnen JT; Bakker E
    Eur J Hum Genet; 2000 Oct; 8(10):793-6. PubMed ID: 11039581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.